SOX9 Governs Differentiation Stage-Specific Gene Expression in Growth Plate Chondrocytes via Direct Concomitant Transactivation and Repression
Cartilage and endochondral bone development require SOX9 activity to regulate chondrogenesis, chondrocyte proliferation, and transition to a non-mitotic hypertrophic state. The restricted and reciprocal expression of the collagen X gene, Col10a1, in hypertrophic chondrocytes and Sox9 in immature chondrocytes epitomise the precise spatiotemporal control of gene expression as chondrocytes progress through phases of differentiation, but how this is achieved is not clear. Here, we have identified a regulatory element upstream of Col10a1 that enhances its expression in hypertrophic chondrocytes in vivo. In immature chondrocytes, where Col10a1 is not expressed, SOX9 interacts with a conserved sequence within this element that is analogous to that within the intronic enhancer of the collagen II gene Col2a1, the known transactivation target of SOX9. By analysing a series of Col10a1 reporter genes in transgenic mice, we show that the SOX9 binding consensus in this element is required to repress expression of the transgene in non-hypertrophic chondrocytes. Forced ectopic Sox9 expression in hypertrophic chondrocytes in vitro and in mice resulted in down-regulation of Col10a1. Mutation of a binding consensus motif for GLI transcription factors, which are the effectors of Indian hedgehog signaling, close to the SOX9 site in the Col10a1 regulatory element, also derepressed transgene expression in non-hypertrophic chondrocytes. GLI2 and GLI3 bound to the Col10a1 regulatory element but not to the enhancer of Col2a1. In addition to Col10a1, paired SOX9–GLI binding motifs are present in the conserved non-coding regions of several genes that are preferentially expressed in hypertrophic chondrocytes and the occurrence of pairing is unlikely to be by chance. We propose a regulatory paradigm whereby direct concomitant positive and negative transcriptional control by SOX9 ensures differentiation phase-specific gene expression in chondrocytes. Discrimination between these opposing modes of transcriptional control by SOX9 may be mediated by cooperation with different partners such as GLI factors.
Vyšlo v časopise:
SOX9 Governs Differentiation Stage-Specific Gene Expression in Growth Plate Chondrocytes via Direct Concomitant Transactivation and Repression. PLoS Genet 7(11): e32767. doi:10.1371/journal.pgen.1002356
Kategorie:
Research Article
prolekare.web.journal.doi_sk:
https://doi.org/10.1371/journal.pgen.1002356
Souhrn
Cartilage and endochondral bone development require SOX9 activity to regulate chondrogenesis, chondrocyte proliferation, and transition to a non-mitotic hypertrophic state. The restricted and reciprocal expression of the collagen X gene, Col10a1, in hypertrophic chondrocytes and Sox9 in immature chondrocytes epitomise the precise spatiotemporal control of gene expression as chondrocytes progress through phases of differentiation, but how this is achieved is not clear. Here, we have identified a regulatory element upstream of Col10a1 that enhances its expression in hypertrophic chondrocytes in vivo. In immature chondrocytes, where Col10a1 is not expressed, SOX9 interacts with a conserved sequence within this element that is analogous to that within the intronic enhancer of the collagen II gene Col2a1, the known transactivation target of SOX9. By analysing a series of Col10a1 reporter genes in transgenic mice, we show that the SOX9 binding consensus in this element is required to repress expression of the transgene in non-hypertrophic chondrocytes. Forced ectopic Sox9 expression in hypertrophic chondrocytes in vitro and in mice resulted in down-regulation of Col10a1. Mutation of a binding consensus motif for GLI transcription factors, which are the effectors of Indian hedgehog signaling, close to the SOX9 site in the Col10a1 regulatory element, also derepressed transgene expression in non-hypertrophic chondrocytes. GLI2 and GLI3 bound to the Col10a1 regulatory element but not to the enhancer of Col2a1. In addition to Col10a1, paired SOX9–GLI binding motifs are present in the conserved non-coding regions of several genes that are preferentially expressed in hypertrophic chondrocytes and the occurrence of pairing is unlikely to be by chance. We propose a regulatory paradigm whereby direct concomitant positive and negative transcriptional control by SOX9 ensures differentiation phase-specific gene expression in chondrocytes. Discrimination between these opposing modes of transcriptional control by SOX9 may be mediated by cooperation with different partners such as GLI factors.
Zdroje
1. AlmanBA 2008 Skeletal dysplasias and the growth plate. Clin Genet 73 24 30
2. KarsentyG 2008 Transcriptional control of skeletogenesis. Annu Rev Genomics Hum Genet 9 183 196
3. KronenbergHM 2006 PTHrP and skeletal development. Ann N Y Acad Sci 1068 1 13
4. BiWDengJMZhangZBehringerRRDe CrombruggheB 1999 Sox9 is required for cartilage formation. Nat Genet 22 85 89
5. BiWHuangWWhitworthDJDengJMZhangZ 2001 Haploinsufficiency of Sox9 results in defective cartilage primordia and premature skeletal mineralization. Proc Natl Acad Sci U S A 98 6698 6703
6. AkiyamaHChaboissierMCMartinJFSchedlADe CrombruggheB 2002 The transcription factor Sox9 has essential roles in successive steps of the chondrocyte differentiation pathway and is required for expression of Sox5 and Sox6. Genes Dev 16 2813 2828
7. IkegamiDAkiyamaHSuzukiANakamuraTNakanoT 2011 Sox9 sustains chondrocyte survival and hypertrophy in part through Pik3ca-Akt pathways. Development 138 1507 1519
8. ZhaoQEberspaecherHLefebvreVDe-CrombruggheB 1997 Parallel expression of Sox9 and Col2a1 in cells undergoing chondrogenesis. Dev Dyn 209 377 386
9. NgLJWheatleySMuscatGEConwayCJBowlesJ 1997 SOX9 binds DNA, activates transcription, and coexpresses with type II collagen during chondrogenesis in the mouse. Dev Biol 183 108 121
10. BellDMLeungKKWheatleySCNgLJZhouS 1997 SOX9 directly regulates the type-II collagen gene. Nat Genet 16 174 178
11. LefebvreVHuangWHarleyVRGoodfellowPNDe-CrombruggheB 1997 SOX9 is a potent activator of the chondrocyte-specific enhancer of the pro alpha1(II) collagen gene. Mol Cell Biol 17 2336 2346
12. LiuYLiHTanakaKTsumakiNYamadaY 2000 Identification of an enhancer sequence within the first intron required for cartilage-specific transcription of the alpha2(XI) collagen gene. J Biol Chem 275 12712 12718
13. SekiyaITsujiKKoopmanPWatanabeHYamadaY 2000 SOX9 enhances aggrecan gene promoter/enhancer activity and is up-regulated by retinoic acid in a cartilage-derived cell line, TC6. J Biol Chem 275 10738 10744
14. XieWFZhangXSakanoSLefebvreVSandellLJ 1999 Trans-activation of the mouse cartilage-derived retinoic acid-sensitive protein gene by Sox9. J Bone Miner Res 14 757 763
15. HanYLefebvreV 2008 L-Sox5/Sox6 Drive Expression of the Aggrecan Gene in Cartilage by Securing Binding of Sox9 to a Far-upstream Enhancer. Mol Cell Biol 28 4999 5013
16. RosatiRHoranGSPineroGJGarofaloSKeeneDR 1994 Normal long bone growth and development in type X collagen-null mice. Nat Genet 8 129 135
17. KwanKMPangMKZhouSCowanSKKongRY 1997 Abnormal compartmentalization of cartilage matrix components in mice lacking collagen X: implications for function. J Cell Biol 136 459 471
18. HoMSTsangKYLoRLSusicMMakitieO 2007 COL10A1 nonsense and frame-shift mutations have a gain-of-function effect on the growth plate in human and mouse metaphyseal chondrodysplasia type Schmid. Hum Mol Genet 16 1201 1215
19. ChambersDYoungDAHowardCThomasJTBoamDS 2002 An enhancer complex confers both high-level and cell-specific expression of the human type X collagen gene. FEBS Lett 531 505 508
20. LefebvreVLiPDe CrombruggheB 1998 A new long form of Sox5 (L-Sox5), Sox6 and Sox9 are coexpressed in chondrogenesis and cooperatively activate the type II collagen gene. EMBO J 17 5718 5733
21. TsangKYChanDCheslettDChanWCSoCL 2007 Surviving endoplasmic reticulum stress is coupled to altered chondrocyte differentiation and function. PLoS Biol 5 e44
22. ScottCEWynnSLSesayACruzCCheungM 2010 SOX9 induces and maintains neural stem cells. Nature neuroscience 13 1181 1189
23. WilsonMKoopmanP 2002 Matching SOX: partner proteins and co-factors of the SOX family of transcriptional regulators. Curr Opin Genet Dev 12 441 446
24. KamachiYCheahKSEKondohH 1999 Mechanism of regulatory target selection by the SOX high-mobility-group domain proteins as revealed by comparison of SOX1/2/3 and SOX9 [In Process Citation]. Mol Cell Biol 19 107 120
25. ZhouRBonneaudNYuanCXde Santa BarbaraPBoizetB 2002 SOX9 interacts with a component of the human thyroid hormone receptor-associated protein complex. Nucleic Acids Res 30 3245 3252
26. NishiokaKItohSSuemotoHKannoSGaiZ 2008 Trps1 deficiency enlarges the proliferative zone of growth plate cartilage by upregulation of Pthrp. Bone 43 64 71
27. WuellingMKaiserFJBuelensLABraunholzDShivdasaniRA 2009 Trps1, a regulator of chondrocyte proliferation and differentiation, interacts with the activator form of Gli3. Dev Biol 328 40 53
28. VegaRBMatsudaKOhJBarbosaACYangX 2004 Histone deacetylase 4 controls chondrocyte hypertrophy during skeletogenesis. Cell 119 555 566
29. MauEWhetstoneHYuCHopyanSWunderJS 2007 PTHrP regulates growth plate chondrocyte differentiation and proliferation in a Gli3 dependent manner utilizing hedgehog ligand dependent and independent mechanisms. Dev Biol 305 28 39
30. KoyamaEYoungBNagayamaMShibukawaYEnomoto-IwamotoM 2007 Conditional Kif3a ablation causes abnormal hedgehog signaling topography, growth plate dysfunction, and excessive bone and cartilage formation during mouse skeletogenesis. Development 134 2159 2169
31. Ruiz i AltabaAMasCSteccaB 2007 The Gli code: an information nexus regulating cell fate, stemness and cancer. Trends in cell biology 17 438 447
32. EamesBFSharpePTHelmsJA 2004 Hierarchy revealed in the specification of three skeletal fates by Sox9 and Runx2. Dev Biol 274 188 200
33. ZhouGZhengQEnginFMunivezEChenY 2006 Dominance of SOX9 function over RUNX2 during skeletogenesis. Proc Natl Acad Sci U S A 103 19004 19009
34. SaitoTIkedaTNakamuraKChungUIKawaguchiH 2007 S100A1 and S100B, transcriptional targets of SOX trio, inhibit terminal differentiation of chondrocytes. EMBO Rep 8 504 509
35. YamashitaSAndohMUeno-KudohHSatoTMiyakiS 2009 Sox9 directly promotes Bapx1 gene expression to repress Runx2 in chondrocytes. Exp Cell Res 315 2231 2240
36. RiemerSGebhardSBeierFPoschlEvon derM 2002 Role of c-fos in the regulation of type X collagen gene expression by PTH and PTHrP: Localization of a PTH/PTHrP-responsive region in the human COL10A1 enhancer. J Cell Biochem 86 688 699
37. ZhengQZhouGMorelloRChenYGarcia-RojasX 2003 Type X collagen gene regulation by Runx2 contributes directly to its hypertrophic chondrocyte-specific expression in vivo. J Cell Biol 162 833 842
38. ArnoldMAKimYCzubrytMPPhanDMcAnallyJ 2007 MEF2C transcription factor controls chondrocyte hypertrophy and bone development. Dev Cell 12 377 389
39. GuoJChungUIYangDKarsentyGBringhurstFR 2006 PTH/PTHrP receptor delays chondrocyte hypertrophy via both Runx2-dependent and -independent pathways. Dev Biol 292 116 128
40. InadaMYasuiTNomuraSMiyakeSDeguchiK 1999 Maturational disturbance of chondrocytes in Cbfa1-deficient mice. Dev Dyn 214 279 290
41. LuVPIwamotoMFanningPPacificiMOlsenBR 1993 Multiple negative elements in a gene that codes for an extracellular matrix protein, collagen X, restrict expression to hypertrophic chondrocytes. J Cell Biol 121 1173 1179
42. MageeCNurminskayaMFavermanLGaleraPLinsenmayerTF 2005 SP3/SP1 transcription activity regulates specific expression of collagen type X in hypertrophic chondrocytes. J Biol Chem 280 25331 25338
43. GebhardSPoschlERiemerSBauerEHattoriT 2004 A highly conserved enhancer in mammalian type X collagen genes drives high levels of tissue-specific expression in hypertrophic cartilage in vitro and in vivo. Matrix Biol 23 309 322
44. HattoriTMullerCGebhardSBauerEPauschF 2010 SOX9 is a major negative regulator of cartilage vascularization, bone marrow formation and endochondral ossification. Development 137 901 911
45. KondohHKamachiY 2009 SOX-partner code for cell specification: Regulatory target selection and underlying molecular mechanisms. Int J Biochem Cell Biol 42 391 399
46. AkiyamaHStadlerHSMartinJFIshiiTMBeachyPA 2007 Misexpression of Sox9 in mouse limb bud mesenchyme induces polydactyly and rescues hypodactyly mice. Matrix Biol 26 224 233
47. St-JacquesBHammerschmidtMMcMahonAP 1999 Indian hedgehog signaling regulates proliferation and differentiation of chondrocytes and is essential for bone formation. Genes Dev 13 2072 2086
48. MoRFreerAMZinykDLCrackowerMAMichaudJ 1997 Specific and redundant functions of Gli2 and Gli3 zinc finger genes in skeletal patterning and development. Development 124 113 123
49. ParkHLBaiCPlattKAMatiseMPBeeghlyA 2000 Mouse Gli1 mutants are viable but have defects in SHH signaling in combination with a Gli2 mutation. Development 127 1593 1605
50. JiangJHuiCC 2008 Hedgehog signaling in development and cancer. Dev Cell 15 801 812
51. JoengKSLongF 2009 The Gli2 transcriptional activator is a crucial effector for Ihh signaling in osteoblast development and cartilage vascularization. Development 136 4177 4185
52. KozielLWuellingMSchneiderSVortkampA 2005 Gli3 acts as a repressor downstream of Ihh in regulating two distinct steps of chondrocyte differentiation. Development 132 5249 5260
53. MakKKKronenbergHMChuangPTMackemSYangY 2008 Indian hedgehog signals independently of PTHrP to promote chondrocyte hypertrophy. Development 135 1947 1956
54. OhCDMaitySNLuJFZhangJLiangS Identification of SOX9 interaction sites in the genome of chondrocytes. PLoS One 5 e10113
55. HuangBLBruggerSMLyonsKM Stage-specific control of connective tissue growth factor (CTGF/CCN2) expression in chondrocytes by Sox9 and beta-catenin. J Biol Chem 285 27702 27712
56. AmanoKHataKSugitaATakigawaYOnoK 2009 Sox9 family members negatively regulate maturation and calcification of chondrocytes through up-regulation of parathyroid hormone-related protein. Mol Biol Cell 20 4541 4551
57. KobayashiTChungUISchipaniEStarbuckMKarsentyG 2002 PTHrP and Indian hedgehog control differentiation of growth plate chondrocytes at multiple steps. Development 129 2977 2986
58. ChenXMacicaCMDreyerBEHammondVEHensJR 2006 Initial characterization of PTH-related protein gene-driven lacZ expression in the mouse. J Bone Miner Res 21 113 123
59. CheungMChaboissierMCMynettAHirstESchedlA 2005 The transcriptional control of trunk neural crest induction, survival, and delamination. Developmental cell 8 179 192
60. Hernandez-HernandezJMDelgado-OlguinPAguillon-HuertaVFurlan-MagarilMRecillas-TargaF 2009 Sox9 represses alpha-sarcoglycan gene expression in early myogenic differentiation. Journal of molecular biology 394 1 14
61. NagyAKenesiERentsendorjOMolnarASzenasiT 2011 Evolutionarily conserved, growth plate zone-specific regulation of the matrilin-1 promoter: L-Sox5/Sox6 and Nfi factors bound near TATA finely tune activation by Sox9. Molecular and cellular biology 31 686 699
62. LefebvreVGarofaloSDe CrombruggheB 1995 Type X collagen gene expression in mouse chondrocytes immortalized by a temperature-sensitive simian virus 40 large tumor antigen. J Cell Biol 128 239 245
63. MukhopadhyayKLefebvreVZhouGGarofaloSKimuraJH 1995 Use of a new rat chondrosarcoma cell line to delineate a 119-base pair chondrocyte-specific enhancer element and to define active promoter segments in the mouse pro-alpha 1(II) collagen gene. J Biol Chem 270 27711 27719
64. WilhelmDMartinsonFBradfordSWilsonMJCombesAN 2005 Sertoli cell differentiation is induced both cell-autonomously and through prostaglandin signaling during mammalian sex determination. Dev Biol 287 111 124
65. DucyPZhangRGeoffroyVRidallALKarsentyG 1997 Osf2/Cbfa1: a transcriptional activator of osteoblast differentiation. Cell 89 747 754
66. NovakAGuoCYangWNagyALobeCG 2000 Z/EG, a double reporter mouse line that expresses enhanced green fluorescent protein upon Cre-mediated excision. Genesis 28 147 155
67. SekidoRLovell-BadgeR 2008 Sex determination involves synergistic action of SRY and SF1 on a specific Sox9 enhancer. Nature 453 930 934
68. KongRYKwanKMLauETThomasJTBoot-HandfordRP 1993 Intron-exon structure, alternative use of promoter and expression of the mouse collagen X gene, Col10a-1. Eur J Biochem 213 99 111
Štítky
Genetika Reprodukčná medicínaČlánok vyšiel v časopise
PLOS Genetics
2011 Číslo 11
- Gynekologové a odborníci na reprodukční medicínu se sejdou na prvním virtuálním summitu
- Je „freeze-all“ pro všechny? Odborníci na fertilitu diskutovali na virtuálním summitu
Najčítanejšie v tomto čísle
- Evidence-Based Annotation of Gene Function in MR-1 Using Genome-Wide Fitness Profiling across 121 Conditions
- De Novo Origins of Human Genes
- TRY-5 Is a Sperm-Activating Protease in Seminal Fluid
- Relative Burden of Large CNVs on a Range of Neurodevelopmental Phenotypes